Signal Hill is pleased to announce that its client SinfoníaRx (https://sinfoniarx.com/), the industry leader in Medication Therapy Management (MTM) technology and services for Medicare, Medicaid and Commercial Health plans, has been acquired by Tabula Rasa HealthCare (NASDAQ:TRHC).
SinfoníaRx is a rapidly growing healthcare company offering innovative solutions for health entities, patients and caregivers. SinfoníaRx works directly with patients, their providers, and community pharmacists to ensure optimal treatment while reducing the risk of adverse events and drug interactions.
Tabula Rasa is a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software solutions and novel, proprietary medication decision support tools.*
*Signal Hill is a legacy firm of DC Advisory US. Find out more >